Sweden· SE-20140702000237
Bortezomib Accord 3,5 mg Pulver till injektionsvätska, lösning
A medicinal product containing bortezomib, registered in Sweden by Accord Healthcare S.L.U..
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Bortezomib
- Manufacturer
- Accord Healthcare S.L.U.
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20140702000237
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bortezomib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainBORTEZOMIB ACCORD 3,5 MG POLVO PARA SOLUCION INYECTABLE EFGAccord Healthcare S.L.U.
- United KingdomBortezomib 3.5mg powder for solution for injection vialsAccord-UK Ltd
- PolandBortezomib AccordAccord Healthcare S.L.U.
- IcelandBortezomib AccordAccord Healthcare S.L.U.
- CzechiaBORTEZOMIB ACCORDAccord Healthcare S.L.U., Barcelona
- FinlandBortezomib EbeweEbewe Pharma Ges.m.b.H. Nfg.KG
- NorwayBortezomib mylanMylan
- BelgiumBortezomib Baxter 3.5 mgBaxter Holding
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Abormib, Bortezomib Ever Pharma
- Belgium · Bortezomib Eg, Bortezomib Eugia
- Bulgaria · Bortezomib Ever Pharma, Бортезомиб Актавис
- Cyprus · Bortezomib Pharmazac, Bortezomib Stada
- Czechia · Bortezomib Ever Pharma, Bortezomib Msn
- Germany · Bortezomib, Bortezomib Amarox
- Denmark · Bortezomib Actavis, Bortezomib Ever Pharma
- Spain · Bortezomib Aurovitas, Bortezomib Combix
- Finland · Bortezomib Avansor, Bortezomib Ever Pharma
- France · Bortezomib, Bortezomib Arrow
- United Kingdom (Northern Ireland) · Bortezomib, Bortezomib Accord
- Greece · Bortezomib Pharmazac, Bortezomib Sandoz
- Croatia · Bortezomib Alpha-Medical, Bortezomib Ever Pharma
- Hungary · Bortezomib Ever Pharma, Bortezomib Msn
- Ireland · Bortezomib Aspire Pharma (Malta), Bortezomib Biotech Pharma Limited
- Iceland · Bortezomib Accord, Bortezomib Actavis
- Italy · Bortezomib Aurobindo, Bortezomib Dr. Reddy’s
- Liechtenstein · Bortezomib Accord, Bortezomib Fresenius Kabi
- Luxembourg · Bortezomib Eg
- Latvia · Bortezomib Tzf
- Malta · Bortezomib Clonmel, Bortezomib Dr. Reddy’s
- Netherlands · Bortezomib Amarox, Bortezomib Cf
- Norway · Bortezomib Accord, Bortezomib Ever Pharma
- Poland · Adabonib, Bortezomib Eugia
- Portugal · Bortezomib Ever Pharma, Bortezomib Extrovis
- Romania · Bortezomib, Bortezomib Dr. Reddy’s
- Slovenia · Bortezomib Actavis, Bortezomib Ever Pharma
- Slovakia · Bortezomib Ever Pharma, Bortezomib Glenmark
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/64c2fbe6-ddaa-4ef8-a7d7-8281bceb722e GET /v1/drugs/64c2fbe6-ddaa-4ef8-a7d7-8281bceb722e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20140702000237",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20140702000237",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/bortezomib-accord"
}See everything about bortezomib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.